Research News for 2010
-
Hormone Replacement Therapy: Type and Time Used Linked to Increase in Risk
New research confirms that hormone replacement therapy increases the risk of hormone-receptor-positive breast cancer.
-
Number of White Girls Going Through Puberty at Younger Age Doubles
The number of white girls going through puberty at a younger age has doubled since the late 1990s, possibly increasing their future risk of breast cancer.
-
Male Relative with Breast Cancer Increases Risk Perception
Having a male relative diagnosed with breast cancer makes family members more aware of their own increased breast cancer risk, but doesn't make them more likely to do anything about this risk.
-
FDA Issues Warning on Evamist Spray
The U.S. Food and Drug Administration is warning women who use Evamist that children and pets shouldn't touch the skin where the HRT is sprayed.
-
Experimental Genomic Test May Help Predict Risk of Hormone-Receptor-Positive Disease Recurrence
An experimental test may be able to help predict the risk of hormone-receptor-positive breast cancer, but it's not clear how useful the test is.
-
Mammograms Less Sensitive in Young Women
Research suggests that breast cancers diagnosed in younger women are more likely to be advanced not because the cancers grow faster than cancers in older women, but because more time passes before the cancer can found by a mammogram.
-
Expert Panel Votes Against Continuing Approval for Avastin to Treat Metastatic Breast Cancer
A panel of experts voted against continuing the approval of Avastin in combination with Taxol to treat metastatic, HER2-negative breast cancer and also voted unanimously against approving Avastin in combination with other chemotherapy medicines to treat metastatic breast cancer.
-
Avastin Doesn’t Improve Survival in Metastatic Breast Cancer
The FDA is considering whether to continue the approval for using Avastin with Taxol to treat metastatic breast cancer, as well as whether to approve it in combination with other medicines.
-
New Guidelines Prefer Aromatase Inhibitors Over Tamoxifen
The American Society of Clinical Oncology has issued new guidelines on taking hormonal therapy medicines after breast cancer surgery.
-
Losing Weight Might Ease Hot Flashes
A very small study suggests hot flashes may be eased by participating in an intensive healthy lifestyle program.
